Advertisement

< Back to Article

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial

Table 1

Baseline characteristics of the participants; full analysis set*.

Table 1

doi: https://doi.org/10.1371/journal.pmed.1003865.t001